Startups
-
A Startup’s Flexibility With ADC Cancer Drugs Attracts €128M for Clinical Trials
Tubulis’s next-generation ADC cancer drugs are designed to overcome limitations of currently available therapies in this drug class. The new financing will support clinical trial plans, but first, preclinical proof-of-concept data will be presented during the American Association for Cancer Research annual meeting.
-
Register for MedCity INVEST Where Startups and Investors Connect
The boutique healthcare conference in Chicago is scheduled for May 21-22 at the Ritz Carlton hotel.
-
Healthcare VC Jumpstart Foundry Now Accepting Applications for Fall Funding
Early-stage healthcare innovation fund Jumpstart Foundry is accepting Fall funding applications through September 30th. Read on to find out why Jumpstart Foundry could be the missing piece in your startup’s journey to making a lasting difference in healthcare.
-
Health Tech, MedCitizens, Startups
StartUPDATES: New Developments from Healthcare Startups
Check out news from Band Connect, Fijoya, Team8, and BrainCheck.
-
Health Tech, Hospitals, Startups
6 Mistakes Digital Health Startups Make When Seeking Funding or Customers
At ViVE, investors and health system executives shared their biggest pet peeves when it comes to pitches from digital health startups.
-
Health Tech, Hospitals, Startups
These 3 Changes Must Occur for Hospitals to See Greater ROI from Their AI Investments
Most health systems aren’t seeing a huge ROI from their AI investments yet. There are three changes that must happen in order for health systems to start seeing a greater ROI when it comes to AI deployments, according to Michael Kalishman, chief venture officer at Virginia-based Sentara Health.
-
Consumer / Employer, Devices & Diagnostics, Health Tech, Payers, Startups
9 ViVE Announcements You Don’t Want to Miss
This year’s ViVE conference featured a variety of news announcements — from company launches to new products to partnerships to acquisitions and more. In this list, MedCity News compiled short summaries for nine of the conference’s most notable announcements.
-
StartUPDATES: New developments from healthcare startups
Check out news from Alpha Sophia, Abridge, Baseimmune, Carewell, and Redi Health.
-
Roots Start to Show for Hair Loss Startup Pelage With a Peek at First Clinical Data
Regenerative medicine startup Pelage Pharmaceuticals has clinical data showing its small molecule activated hair follicle stem cells. GV led a Series A round that funded the UCLA spinout’s Phase 1 clinical trial and will also support Phase 2 testing this year.
-
Growth or Profitability: Which One Do Investors Care More About?
In the venture capital community, there’s a bit of a debate about what matters more to digital health investors in today’s fundraising environment — growth or profitability. Cathy Gao, a partner at Sapphire Ventures, thinks VCs are still putting a premium on growth, but she noted that the conversation is very nuanced.
-
Health Tech, Hospitals, Startups
16 Health Systems Help Launch Health & Wellness Marketplace
Vale Health announced its launch on Monday at ViVE. The startup’s platform helps health systems connect their patients to health and wellness products, which are becoming increasingly interesting to consumers. Vale has 16 founding health systems partners that will go live with the platform, with the Froedtert & the Medical College of Wisconsin health network being the first.
-
Lose Fat, Not Muscle: Next Test for Lilly’s Zepbound Pairs It With BioAge Drug
In preclinical testing, combining BioAge Labs’ experimental drug with Eli Lilly weight drug Zepbound led to greater weight loss compared with Zepbound alone. Now the company plans to run a Phase 2 study to see if it can replicate those results in humans.
-
Network With Healthcare Investors at MedCity INVEST 2024!
The conference, scheduled for May 21-22 at the Ritz Carlton hotel in Chicago, brings together healthcare investors, startups, and innovative-minded executives. Register today!
-
Health Tech, Hospitals, Startups
Meet the Marketplace Providers Are Using to Overcome the ‘Notorious Challenge’ of Radiology AI Adoption
About 80% of all FDA-approved healthcare AI applications are related to radiology — but due to a massive workforce shortage, radiologists don’t have the time to explore, choose, validate and implement the tools available to them. Some providers are using a radiology AI marketplace called CARPL to address this problem, including Massachusetts General Hospital and University Hospitals.
-
BioPharma, Devices & Diagnostics, Health Tech, Startups
Healthcare Startups, Time is Running Out to Enter the MedCity INVEST Pitch Perfect Contest in Chicago
Are you a biopharma startup focused on oncology? A devices /diagnostics startup focused on cardiology? Or a health tech startup focused on how consumers/employers
are addressing women’s health? If so, submit an application for MedCity INVEST Pitch Perfect by February 29!